Instant-needs platform Gopuff has launched Goodnow, a private label line of health-and-wellness products designed to help customers feel better faster for less money.
“Health and wellness – an $80-plus billion market in the U.S. – has been one of Gopuff’s fastest-growing categories,” noted Jessica Glendenning, director of private label at Philadelphia-based Gopuff. “As consumers become increasingly interested in private label products, Gopuff is uniquely positioned to develop new brands curated specifically for our customers. Informed by data, insights and feedback, … Goodnow is an inherent fit for our customers and the Gopuff platform.”
When surveyed, customers identified over-the-counter medications as a great fit for Gopuff. They also expressed interest in getting pain relievers, cold and flu remedies, allergy medications, and first aid from the platform. Now Gopuff customers can order Goodnow pain (ibuprofen, acetaminophen, naproxen, headache relief); allergy (loratadine, cetirizine, diphenhydramine); cold; flu and sinus congestion relief; sleep aid products; and at-home diagnostic test kits (UTI, BV, herpes) for delivery in minutes. Additional Goodnow products, among them electrolyte drinks, bandages, antihistamines and antacids, will launch nationwide over the coming months.
All Goodnow products are produced and controlled in accordance with quality standards and manufactured in a third-party GMP-certified facility.
Goodnow builds on the early success of Gopuff’s first private label offering, Basically, which came out in January and is consistently among the platform’s top 10 brands for Gopuff.
Philadelphia-based Gopuff is No. 79 on The PG 100, Progressive Grocer’s 2022 list of the top food and consumables retailers in North America.